LGOSX
Price
$25.41
Change
-$1.25 (-4.69%)
Updated
Dec 18 closing price
PAMCX
Price
$94.06
Change
-$3.25 (-3.34%)
Updated
Dec 18 closing price
Ad is loading...

LGOSX vs PAMCX

Header iconLGOSX vs PAMCX Comparison
Open Charts LGOSX vs PAMCXBanner chart's image
Lord Abbett Growth Opportunities R4
Price$25.41
Change-$1.25 (-4.69%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth Adv
Price$94.06
Change-$3.25 (-3.34%)
VolumeN/A
CapitalizationN/A
LGOSX vs PAMCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LGOSX vs. PAMCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGOSX is a Buy and PAMCX is a Hold.

FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 31.4B vs. LGOSX (553M). LGOSX (0.00) and PAMCX (0.00) have matching dividends . LGOSX was incepted earlier than PAMCX: LGOSX (9 years) vs PAMCX (25 years). LGOSX is a more actively managed with annual turnover of: 149.00 vs. PAMCX (21.70). LGOSX has a lower initial minimum investment than PAMCX: LGOSX (0) vs PAMCX (2500). LGOSX annual gain was more profitable for investors over the last year : 38.13 vs. PAMCX (3.76). LGOSX return over 5 years is better than : 11.83 vs. PAMCX (6.33).
LGOSXPAMCXLGOSX / PAMCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years25 years-
Gain YTD37.4232.4211,546%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets553M31.4B2%
Annual Yield % from dividends0.000.00-
Returns for 1 year38.133.761,013%
Returns for 3 years6.38-10.39-61%
Returns for 5 years11.836.33187%
Returns for 10 yearsN/A31.73-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GMRE8.460.06
+0.71%
Global Medical REIT
ABOS1.96-0.01
-0.51%
Acumen Pharmaceuticals
CMPR78.53-1.96
-2.44%
Cimpress plc
OTEX28.63-0.94
-3.18%
Open Text Corp
VCNX1.41-2.24
-61.37%
Vaccinex